

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-linolenic acid metabolic process (GO:0036109) | 3.94743152 |
| 2 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.91407834 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.89217116 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 3.89217116 |
| 5 | rhodopsin mediated signaling pathway (GO:0016056) | 3.85738889 |
| 6 | lysine metabolic process (GO:0006553) | 3.81708712 |
| 7 | lysine catabolic process (GO:0006554) | 3.81708712 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.74987703 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.71849483 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 3.71849483 |
| 11 | protein localization to endosome (GO:0036010) | 3.70247236 |
| 12 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.49919256 |
| 13 | retinal cone cell development (GO:0046549) | 3.49613021 |
| 14 | sodium ion export (GO:0071436) | 3.38901480 |
| 15 | synaptic vesicle maturation (GO:0016188) | 3.35606673 |
| 16 | aspartate family amino acid catabolic process (GO:0009068) | 3.35307677 |
| 17 | glutamate metabolic process (GO:0006536) | 3.28846766 |
| 18 | mannose metabolic process (GO:0006013) | 3.27677093 |
| 19 | aromatic amino acid family catabolic process (GO:0009074) | 3.26519580 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.26242642 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.25441420 |
| 22 | cellular ketone body metabolic process (GO:0046950) | 3.24267697 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.23582908 |
| 24 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.22295525 |
| 25 | glyoxylate metabolic process (GO:0046487) | 3.16774890 |
| 26 | cellular potassium ion homeostasis (GO:0030007) | 3.14445645 |
| 27 | cysteine metabolic process (GO:0006534) | 3.09958322 |
| 28 | kynurenine metabolic process (GO:0070189) | 3.07271694 |
| 29 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.05925207 |
| 30 | short-chain fatty acid metabolic process (GO:0046459) | 3.04023434 |
| 31 | locomotory exploration behavior (GO:0035641) | 3.02886234 |
| 32 | negative regulation of fatty acid transport (GO:2000192) | 3.00254129 |
| 33 | bile acid biosynthetic process (GO:0006699) | 2.99816587 |
| 34 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.99684882 |
| 35 | carnitine shuttle (GO:0006853) | 2.99430953 |
| 36 | 2-oxoglutarate metabolic process (GO:0006103) | 2.97643167 |
| 37 | regulation of early endosome to late endosome transport (GO:2000641) | 2.97244886 |
| 38 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.97016437 |
| 39 | fatty acid transmembrane transport (GO:1902001) | 2.96872868 |
| 40 | regulation of cholesterol homeostasis (GO:2000188) | 2.92883870 |
| 41 | phototransduction (GO:0007602) | 2.92608139 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 2.92329966 |
| 43 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.89783528 |
| 44 | sulfur amino acid catabolic process (GO:0000098) | 2.87729217 |
| 45 | phototransduction, visible light (GO:0007603) | 2.87138016 |
| 46 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.85454123 |
| 47 | photoreceptor cell development (GO:0042461) | 2.84278986 |
| 48 | urea cycle (GO:0000050) | 2.84061476 |
| 49 | urea metabolic process (GO:0019627) | 2.84061476 |
| 50 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.82042948 |
| 51 | detection of light stimulus involved in visual perception (GO:0050908) | 2.82042948 |
| 52 | ketone body metabolic process (GO:1902224) | 2.81350139 |
| 53 | dicarboxylic acid catabolic process (GO:0043649) | 2.81172381 |
| 54 | cellular modified amino acid catabolic process (GO:0042219) | 2.80973073 |
| 55 | fatty acid beta-oxidation (GO:0006635) | 2.79220517 |
| 56 | acetyl-CoA metabolic process (GO:0006084) | 2.78326044 |
| 57 | detection of light stimulus (GO:0009583) | 2.77349329 |
| 58 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.77252455 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 2.77146658 |
| 60 | amino-acid betaine transport (GO:0015838) | 2.77049980 |
| 61 | carnitine transport (GO:0015879) | 2.77049980 |
| 62 | regulation of ARF protein signal transduction (GO:0032012) | 2.73274876 |
| 63 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.73229426 |
| 64 | glutamate secretion (GO:0014047) | 2.73056111 |
| 65 | detection of visible light (GO:0009584) | 2.72536875 |
| 66 | cell communication by electrical coupling (GO:0010644) | 2.72322888 |
| 67 | tryptophan catabolic process (GO:0006569) | 2.72110074 |
| 68 | indole-containing compound catabolic process (GO:0042436) | 2.72110074 |
| 69 | indolalkylamine catabolic process (GO:0046218) | 2.72110074 |
| 70 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.72028337 |
| 71 | potassium ion import (GO:0010107) | 2.69803339 |
| 72 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.69761424 |
| 73 | high-density lipoprotein particle remodeling (GO:0034375) | 2.69739007 |
| 74 | gamma-aminobutyric acid transport (GO:0015812) | 2.65884229 |
| 75 | positive regulation of extracellular matrix organization (GO:1903055) | 2.65866225 |
| 76 | positive regulation of fatty acid oxidation (GO:0046321) | 2.65490538 |
| 77 | eye photoreceptor cell development (GO:0042462) | 2.64650805 |
| 78 | fatty acid oxidation (GO:0019395) | 2.63404666 |
| 79 | carnitine transmembrane transport (GO:1902603) | 2.63227491 |
| 80 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.63163548 |
| 81 | alpha-amino acid catabolic process (GO:1901606) | 2.62549122 |
| 82 | NADH metabolic process (GO:0006734) | 2.62458373 |
| 83 | modulation by symbiont of host cellular process (GO:0044068) | 2.62227563 |
| 84 | lipid oxidation (GO:0034440) | 2.60957573 |
| 85 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.60017395 |
| 86 | phosphate ion transport (GO:0006817) | 2.59948592 |
| 87 | barbed-end actin filament capping (GO:0051016) | 2.59580193 |
| 88 | nitrogen cycle metabolic process (GO:0071941) | 2.58238802 |
| 89 | regulation of fatty acid oxidation (GO:0046320) | 2.58115690 |
| 90 | photoreceptor cell maintenance (GO:0045494) | 2.57833757 |
| 91 | fatty acid catabolic process (GO:0009062) | 2.57463443 |
| 92 | drug catabolic process (GO:0042737) | 2.57392860 |
| 93 | serine family amino acid catabolic process (GO:0009071) | 2.56993402 |
| 94 | cellular amino acid catabolic process (GO:0009063) | 2.56611688 |
| 95 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.55964807 |
| 96 | adhesion of symbiont to host (GO:0044406) | 2.55628337 |
| 97 | positive regulation of lipid catabolic process (GO:0050996) | 2.55241050 |
| 98 | cell-substrate adherens junction assembly (GO:0007045) | 2.54798655 |
| 99 | focal adhesion assembly (GO:0048041) | 2.54798655 |
| 100 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.54417585 |
| 101 | monocarboxylic acid catabolic process (GO:0072329) | 2.54326355 |
| 102 | bile acid metabolic process (GO:0008206) | 2.53546395 |
| 103 | homocysteine metabolic process (GO:0050667) | 2.53294457 |
| 104 | stress fiber assembly (GO:0043149) | 2.52174950 |
| 105 | cellular sodium ion homeostasis (GO:0006883) | 2.51135321 |
| 106 | reverse cholesterol transport (GO:0043691) | 2.51123048 |
| 107 | positive regulation of receptor recycling (GO:0001921) | 2.51084296 |
| 108 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.50671783 |
| 109 | alanine transport (GO:0032328) | 2.50607200 |
| 110 | quaternary ammonium group transport (GO:0015697) | 2.50091570 |
| 111 | carnitine metabolic process (GO:0009437) | 2.49477927 |
| 112 | tryptophan metabolic process (GO:0006568) | 2.49386446 |
| 113 | regulation of extracellular matrix disassembly (GO:0010715) | 2.48771461 |
| 114 | acylglycerol homeostasis (GO:0055090) | 2.48688112 |
| 115 | triglyceride homeostasis (GO:0070328) | 2.48688112 |
| 116 | neurotransmitter secretion (GO:0007269) | 2.48000263 |
| 117 | regulation of guanylate cyclase activity (GO:0031282) | 2.46613116 |
| 118 | adherens junction assembly (GO:0034333) | 2.46259268 |
| 119 | complement activation, alternative pathway (GO:0006957) | 2.46044264 |
| 120 | drug transmembrane transport (GO:0006855) | 2.44494551 |
| 121 | protein-chromophore linkage (GO:0018298) | 2.44454106 |
| 122 | retinal rod cell development (GO:0046548) | 2.43866043 |
| 123 | response to mercury ion (GO:0046689) | 2.43276403 |
| 124 | response to laminar fluid shear stress (GO:0034616) | 2.37207956 |
| 125 | positive regulation of protein dephosphorylation (GO:0035307) | 2.36944873 |
| 126 | virion attachment to host cell (GO:0019062) | 2.35752118 |
| 127 | adhesion of symbiont to host cell (GO:0044650) | 2.35752118 |
| 128 | negative regulation of cell size (GO:0045792) | 2.34439406 |
| 129 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.33208337 |
| 130 | germinal center formation (GO:0002467) | 2.32854676 |
| 131 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.32714892 |
| 132 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.32455010 |
| 133 | cell-substrate junction assembly (GO:0007044) | 2.32323638 |
| 134 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.28877042 |
| 135 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.27608741 |
| 136 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.25935521 |
| 137 | negative regulation of lipid transport (GO:0032369) | 2.24432925 |
| 138 | activation of MAPKKK activity (GO:0000185) | 2.22341268 |
| 139 | modulation by virus of host process (GO:0019054) | 2.22233984 |
| 140 | negative regulation of cell killing (GO:0031342) | 2.19827754 |
| 141 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.19827754 |
| 142 | COPI coating of Golgi vesicle (GO:0048205) | 2.19167169 |
| 143 | Golgi transport vesicle coating (GO:0048200) | 2.19167169 |
| 144 | regulation of extracellular matrix organization (GO:1903053) | 2.18731746 |
| 145 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.18494203 |
| 146 | modulation by symbiont of host immune response (GO:0052553) | 2.18494203 |
| 147 | positive regulation by symbiont of host defense response (GO:0052509) | 2.18494203 |
| 148 | modulation by symbiont of host defense response (GO:0052031) | 2.18494203 |
| 149 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.18494203 |
| 150 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.18494203 |
| 151 | creatine metabolic process (GO:0006600) | 2.18315331 |
| 152 | hypotonic response (GO:0006971) | 2.18091675 |
| 153 | cell volume homeostasis (GO:0006884) | 2.16654825 |
| 154 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.16138662 |
| 155 | macrophage activation involved in immune response (GO:0002281) | 2.15818651 |
| 156 | response to thyroid hormone (GO:0097066) | 2.15398800 |
| 157 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.14134711 |
| 158 | protein-lipid complex assembly (GO:0065005) | 2.13285685 |
| 159 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.13284629 |
| 160 | modulation by virus of host morphology or physiology (GO:0019048) | 2.10546462 |
| 161 | low-density lipoprotein particle clearance (GO:0034383) | 2.09559562 |
| 162 | positive regulation of Rap GTPase activity (GO:0032854) | 2.09248721 |
| 163 | fructose metabolic process (GO:0006000) | 2.09235944 |
| 164 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.09021925 |
| 165 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.08492850 |
| 166 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.08492850 |
| 167 | detection of bacterium (GO:0016045) | 2.08250338 |
| 168 | detection of other organism (GO:0098543) | 2.07215437 |
| 169 | signal complex assembly (GO:0007172) | 2.06916260 |
| 170 | pinocytosis (GO:0006907) | 2.05630724 |
| 171 | activation of Rac GTPase activity (GO:0032863) | 2.05226848 |
| 172 | negative regulation of viral release from host cell (GO:1902187) | 2.03856602 |
| 173 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.03536128 |
| 174 | response to type I interferon (GO:0034340) | 2.02629195 |
| 175 | glycosphingolipid catabolic process (GO:0046479) | 2.02389497 |
| 176 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.02304532 |
| 177 | positive regulation of myotube differentiation (GO:0010831) | 2.02217970 |
| 178 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.02211625 |
| 179 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.01881281 |
| 180 | skeletal muscle adaptation (GO:0043501) | 2.01729176 |
| 181 | regulation of cholesterol storage (GO:0010885) | 2.01526114 |
| 182 | thymic T cell selection (GO:0045061) | 2.00172265 |
| 183 | protein carboxylation (GO:0018214) | 2.00007069 |
| 184 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.00007069 |
| 185 | positive regulation of macrophage cytokine production (GO:0060907) | 1.99350008 |
| 186 | cellular response to type I interferon (GO:0071357) | 1.99174585 |
| 187 | type I interferon signaling pathway (GO:0060337) | 1.99174585 |
| 188 | response to muramyl dipeptide (GO:0032495) | 1.98137299 |
| 189 | negative regulation of fibrinolysis (GO:0051918) | 1.97700780 |
| 190 | response to peptidoglycan (GO:0032494) | 1.97621831 |
| 191 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 1.97523538 |
| 192 | cortical actin cytoskeleton organization (GO:0030866) | 1.96441666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.53739395 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.38283960 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.86564734 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.86246692 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.80910285 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.80486075 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.52900135 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.42855375 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.35803568 |
| 10 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.34644776 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.21326653 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.12474946 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11183861 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.10391608 |
| 15 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.09443913 |
| 16 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.06147532 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.03506298 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.03202080 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.81312129 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.78174323 |
| 21 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.74879858 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.74072351 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68570758 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.67106345 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66698354 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.63265727 |
| 27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.62971320 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61659537 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.61038089 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.61038089 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.58407080 |
| 32 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.53749279 |
| 33 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.52768990 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.52405108 |
| 35 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52244667 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.51266576 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50990500 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.49125431 |
| 39 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48866465 |
| 40 | GATA1_19941826_ChIP-Seq_K562_Human | 1.47840853 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46679880 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44711572 |
| 43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.43246479 |
| 44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43003530 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41041174 |
| 46 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.40088979 |
| 47 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.39970241 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39363039 |
| 49 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.39278180 |
| 50 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37888088 |
| 51 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35811854 |
| 52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35401492 |
| 53 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.34696467 |
| 54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.34645937 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.34317393 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34191031 |
| 57 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.33034233 |
| 58 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32424239 |
| 59 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32145136 |
| 60 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.31870614 |
| 61 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.31796119 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31165535 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31073809 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30501085 |
| 65 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.30495678 |
| 66 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30100251 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28990626 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27998200 |
| 69 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27417091 |
| 70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27259339 |
| 71 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.26353587 |
| 72 | P68_20966046_ChIP-Seq_HELA_Human | 1.26343608 |
| 73 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26198960 |
| 74 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25064394 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24904940 |
| 76 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23570250 |
| 77 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.23421836 |
| 78 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.23328444 |
| 79 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.20554002 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20053904 |
| 81 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.19936056 |
| 82 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16674567 |
| 83 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16647245 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15867712 |
| 85 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.15790548 |
| 86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15403977 |
| 87 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14971492 |
| 88 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.14728830 |
| 89 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14206549 |
| 90 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.14173578 |
| 91 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.12762850 |
| 92 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.11752809 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11478299 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10960628 |
| 95 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10481394 |
| 96 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.09578055 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08985348 |
| 98 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08202931 |
| 99 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08097106 |
| 100 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08074436 |
| 101 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.08007794 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07833839 |
| 103 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06741533 |
| 104 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06119268 |
| 105 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.05944446 |
| 106 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.05119631 |
| 107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04940207 |
| 108 | MAF_26560356_Chip-Seq_TH2_Human | 1.04131987 |
| 109 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04118563 |
| 110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03742093 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02697887 |
| 112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02358183 |
| 113 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02192131 |
| 114 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.01093268 |
| 115 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00060111 |
| 116 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00060111 |
| 117 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99682457 |
| 118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99446337 |
| 119 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99050266 |
| 120 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.97683041 |
| 121 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97502199 |
| 122 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97218566 |
| 123 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97168828 |
| 124 | * AR_19668381_ChIP-Seq_PC3_Human | 0.97112022 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94176139 |
| 126 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93981961 |
| 127 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93971103 |
| 128 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92705596 |
| 129 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92447627 |
| 130 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91651660 |
| 131 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89654102 |
| 132 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89619670 |
| 133 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89538615 |
| 134 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.88337672 |
| 135 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.87903359 |
| 136 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87732572 |
| 137 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86968718 |
| 138 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86910001 |
| 139 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86562962 |
| 140 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.86547112 |
| 141 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85398077 |
| 142 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.84585585 |
| 143 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83613469 |
| 144 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.83200969 |
| 145 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82776715 |
| 146 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81813798 |
| 147 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.81146627 |
| 148 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.80994864 |
| 149 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.79452614 |
| 150 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.78726028 |
| 151 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.77376327 |
| 152 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76963759 |
| 153 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76493180 |
| 154 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.76462943 |
| 155 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.75599011 |
| 156 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.74457802 |
| 157 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.74433918 |
| 158 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.74265143 |
| 159 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73281668 |
| 160 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.71774285 |
| 161 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.71622107 |
| 162 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.71375715 |
| 163 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.71183536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 4.39035183 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.36412431 |
| 3 | MP0005360_urolithiasis | 4.30093035 |
| 4 | MP0005551_abnormal_eye_electrophysiolog | 3.91111550 |
| 5 | MP0005451_abnormal_body_composition | 3.67271005 |
| 6 | MP0005365_abnormal_bile_salt | 3.20864484 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.13547772 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.97528368 |
| 9 | MP0003303_peritoneal_inflammation | 2.73921993 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.72008660 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.63052940 |
| 12 | MP0003252_abnormal_bile_duct | 2.44469719 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.37725418 |
| 14 | MP0005253_abnormal_eye_physiology | 2.35136398 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.22122797 |
| 16 | MP0003436_decreased_susceptibility_to | 2.11812066 |
| 17 | MP0005409_darkened_coat_color | 2.10617699 |
| 18 | MP0006072_abnormal_retinal_apoptosis | 2.09781601 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.03389198 |
| 20 | MP0005332_abnormal_amino_acid | 1.96605865 |
| 21 | MP0004510_myositis | 1.96422104 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.90972423 |
| 23 | MP0004270_analgesia | 1.89676425 |
| 24 | MP0004130_abnormal_muscle_cell | 1.87681566 |
| 25 | MP0003329_amyloid_beta_deposits | 1.85657835 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 1.82210403 |
| 27 | MP0003635_abnormal_synaptic_transmissio | 1.81850232 |
| 28 | MP0004043_abnormal_pH_regulation | 1.81771992 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.81071047 |
| 30 | MP0002090_abnormal_vision | 1.78379670 |
| 31 | MP0004947_skin_inflammation | 1.74922045 |
| 32 | MP0002822_catalepsy | 1.74701017 |
| 33 | MP0003195_calcinosis | 1.72976505 |
| 34 | MP0003091_abnormal_cell_migration | 1.72714464 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.67834659 |
| 36 | MP0003566_abnormal_cell_adhesion | 1.64570976 |
| 37 | MP0005423_abnormal_somatic_nervous | 1.63258112 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 1.62951721 |
| 39 | MP0000685_abnormal_immune_system | 1.62720994 |
| 40 | MP0003879_abnormal_hair_cell | 1.61077169 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.60515219 |
| 42 | MP0005076_abnormal_cell_differentiation | 1.58470632 |
| 43 | MP0008438_abnormal_cutaneous_collagen | 1.58251346 |
| 44 | MP0009840_abnormal_foam_cell | 1.57771864 |
| 45 | MP0002118_abnormal_lipid_homeostasis | 1.55849426 |
| 46 | MP0004885_abnormal_endolymph | 1.54999240 |
| 47 | MP0003453_abnormal_keratinocyte_physiol | 1.52726348 |
| 48 | MP0002229_neurodegeneration | 1.50760284 |
| 49 | MP0008260_abnormal_autophagy | 1.50323213 |
| 50 | MP0001958_emphysema | 1.48732157 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.48708631 |
| 52 | MP0005670_abnormal_white_adipose | 1.47871695 |
| 53 | MP0000751_myopathy | 1.45707046 |
| 54 | MP0003045_fibrosis | 1.44126205 |
| 55 | MP0002064_seizures | 1.41774119 |
| 56 | MP0005195_abnormal_posterior_eye | 1.40721932 |
| 57 | MP0009046_muscle_twitch | 1.38959262 |
| 58 | MP0005083_abnormal_biliary_tract | 1.37978955 |
| 59 | MP0008961_abnormal_basal_metabolism | 1.37142320 |
| 60 | MP0009745_abnormal_behavioral_response | 1.36909652 |
| 61 | MP0003279_aneurysm | 1.36261193 |
| 62 | MP0002063_abnormal_learning/memory/cond | 1.35852453 |
| 63 | MP0003646_muscle_fatigue | 1.35028112 |
| 64 | MP0001790_abnormal_immune_system | 1.34462292 |
| 65 | MP0005387_immune_system_phenotype | 1.34462292 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.31804549 |
| 67 | MP0001348_abnormal_lacrimal_gland | 1.29315644 |
| 68 | MP0001486_abnormal_startle_reflex | 1.29096646 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.28603594 |
| 70 | MP0001849_ear_inflammation | 1.27129960 |
| 71 | MP0003690_abnormal_glial_cell | 1.26413947 |
| 72 | MP0005025_abnormal_response_to | 1.26131065 |
| 73 | MP0001666_abnormal_nutrient_absorption | 1.24785524 |
| 74 | MP0005535_abnormal_body_temperature | 1.24400481 |
| 75 | MP0005666_abnormal_adipose_tissue | 1.24286505 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.23935645 |
| 77 | MP0000604_amyloidosis | 1.23609370 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.23219785 |
| 79 | MP0001835_abnormal_antigen_presentation | 1.23202453 |
| 80 | MP0005166_decreased_susceptibility_to | 1.23030994 |
| 81 | MP0001324_abnormal_eye_pigmentation | 1.22704037 |
| 82 | MP0002419_abnormal_innate_immunity | 1.20294292 |
| 83 | MP0001764_abnormal_homeostasis | 1.17540971 |
| 84 | MP0004233_abnormal_muscle_weight | 1.16302016 |
| 85 | MP0002272_abnormal_nervous_system | 1.15327933 |
| 86 | MP0003950_abnormal_plasma_membrane | 1.15287004 |
| 87 | MP0000920_abnormal_myelination | 1.14230357 |
| 88 | MP0001533_abnormal_skeleton_physiology | 1.14013431 |
| 89 | MP0005000_abnormal_immune_tolerance | 1.13783046 |
| 90 | MP0003880_abnormal_central_pattern | 1.12722204 |
| 91 | MP0005464_abnormal_platelet_physiology | 1.10563564 |
| 92 | MP0000858_altered_metastatic_potential | 1.09084048 |
| 93 | MP0009278_abnormal_bone_marrow | 1.08862582 |
| 94 | MP0003633_abnormal_nervous_system | 1.08288598 |
| 95 | MP0000609_abnormal_liver_physiology | 1.07739723 |
| 96 | MP0008569_lethality_at_weaning | 1.07111480 |
| 97 | MP0002971_abnormal_brown_adipose | 1.06883363 |
| 98 | MP0004215_abnormal_myocardial_fiber | 1.06631784 |
| 99 | MP0003763_abnormal_thymus_physiology | 1.05707564 |
| 100 | MP0003705_abnormal_hypodermis_morpholog | 1.05433245 |
| 101 | MP0005023_abnormal_wound_healing | 1.04352377 |
| 102 | MP0003806_abnormal_nucleotide_metabolis | 1.03680364 |
| 103 | MP0009785_altered_susceptibility_to | 1.02927883 |
| 104 | MP0004858_abnormal_nervous_system | 1.02890341 |
| 105 | MP0006082_CNS_inflammation | 1.02782203 |
| 106 | MP0002572_abnormal_emotion/affect_behav | 1.01576116 |
| 107 | MP0002734_abnormal_mechanical_nocicepti | 1.00580140 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 1.00135927 |
| 109 | MP0000678_abnormal_parathyroid_gland | 0.99501364 |
| 110 | MP0001984_abnormal_olfaction | 0.97992770 |
| 111 | MP0003656_abnormal_erythrocyte_physiolo | 0.97426242 |
| 112 | MP0000013_abnormal_adipose_tissue | 0.95219887 |
| 113 | MP0001873_stomach_inflammation | 0.94917081 |
| 114 | MP0005310_abnormal_salivary_gland | 0.94546787 |
| 115 | MP0004381_abnormal_hair_follicle | 0.93977259 |
| 116 | MP0000747_muscle_weakness | 0.93760249 |
| 117 | MP0005330_cardiomyopathy | 0.93451062 |
| 118 | MP0002078_abnormal_glucose_homeostasis | 0.93426770 |
| 119 | MP0005410_abnormal_fertilization | 0.92951173 |
| 120 | MP0000733_abnormal_muscle_development | 0.92565816 |
| 121 | MP0005391_vision/eye_phenotype | 0.92405920 |
| 122 | MP0004036_abnormal_muscle_relaxation | 0.92010439 |
| 123 | MP0000759_abnormal_skeletal_muscle | 0.91171841 |
| 124 | MP0002882_abnormal_neuron_morphology | 0.90318750 |
| 125 | MP0001765_abnormal_ion_homeostasis | 0.90124428 |
| 126 | MP0001800_abnormal_humoral_immune | 0.89930925 |
| 127 | MP0001502_abnormal_circadian_rhythm | 0.89515876 |
| 128 | MP0009643_abnormal_urine_homeostasis | 0.89079739 |
| 129 | MP0005375_adipose_tissue_phenotype | 0.89005286 |
| 130 | MP0003075_altered_response_to | 0.88717445 |
| 131 | MP0002166_altered_tumor_susceptibility | 0.88214312 |
| 132 | MP0001968_abnormal_touch/_nociception | 0.88094377 |
| 133 | MP0000003_abnormal_adipose_tissue | 0.88026696 |
| 134 | MP0005623_abnormal_meninges_morphology | 0.87089160 |
| 135 | MP0002896_abnormal_bone_mineralization | 0.85967942 |
| 136 | MP0002148_abnormal_hypersensitivity_rea | 0.83804758 |
| 137 | MP0002332_abnormal_exercise_endurance | 0.83494187 |
| 138 | MP0002067_abnormal_sensory_capabilities | 0.83336992 |
| 139 | MP0009333_abnormal_splenocyte_physiolog | 0.82953137 |
| 140 | MP0002723_abnormal_immune_serum | 0.82898738 |
| 141 | MP0002796_impaired_skin_barrier | 0.82876666 |
| 142 | MP0003634_abnormal_glial_cell | 0.82699914 |
| 143 | MP0003828_pulmonary_edema | 0.82545869 |
| 144 | MP0001501_abnormal_sleep_pattern | 0.81496044 |
| 145 | MP0002452_abnormal_antigen_presenting | 0.81321225 |
| 146 | MP0001440_abnormal_grooming_behavior | 0.81081599 |
| 147 | MP0004087_abnormal_muscle_fiber | 0.79690596 |
| 148 | MP0009115_abnormal_fat_cell | 0.79452720 |
| 149 | MP0002269_muscular_atrophy | 0.79269233 |
| 150 | MP0003631_nervous_system_phenotype | 0.79223867 |
| 151 | MP0005620_abnormal_muscle_contractility | 0.79043649 |
| 152 | MP0002089_abnormal_postnatal_growth/wei | 0.78440232 |
| 153 | MP0003868_abnormal_feces_composition | 0.78130283 |
| 154 | MP0005386_behavior/neurological_phenoty | 0.77490783 |
| 155 | MP0004924_abnormal_behavior | 0.77490783 |
| 156 | MP0003866_abnormal_defecation | 0.77244031 |
| 157 | MP0001845_abnormal_inflammatory_respons | 0.76618000 |
| 158 | MP0004145_abnormal_muscle_electrophysio | 0.76548115 |
| 159 | MP0005165_increased_susceptibility_to | 0.76537403 |
| 160 | MP0000343_altered_response_to | 0.76377821 |
| 161 | MP0004185_abnormal_adipocyte_glucose | 0.76084001 |
| 162 | MP0002138_abnormal_hepatobiliary_system | 0.75307294 |
| 163 | MP0004085_abnormal_heartbeat | 0.74766270 |
| 164 | MP0006138_congestive_heart_failure | 0.74335958 |
| 165 | MP0003724_increased_susceptibility_to | 0.73934598 |
| 166 | MP0005167_abnormal_blood-brain_barrier | 0.73925238 |
| 167 | MP0008469_abnormal_protein_level | 0.73496794 |
| 168 | MP0002752_abnormal_somatic_nervous | 0.73340093 |
| 169 | MP0008874_decreased_physiological_sensi | 0.73238448 |
| 170 | MP0001756_abnormal_urination | 0.72914224 |
| 171 | MP0004084_abnormal_cardiac_muscle | 0.72764256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 5.91414827 |
| 2 | Bony spicule pigmentary retinopathy (HP:0007737) | 5.15250311 |
| 3 | Central scotoma (HP:0000603) | 5.13824555 |
| 4 | Pigmentary retinal degeneration (HP:0001146) | 4.89155580 |
| 5 | Chorioretinal atrophy (HP:0000533) | 4.43606230 |
| 6 | Scotoma (HP:0000575) | 4.14883840 |
| 7 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.09232066 |
| 8 | Abnormality of macular pigmentation (HP:0008002) | 4.04670768 |
| 9 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.00632756 |
| 10 | Dyschromatopsia (HP:0007641) | 3.99959686 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.51645125 |
| 12 | Abolished electroretinogram (ERG) (HP:0000550) | 3.37683038 |
| 13 | Ketosis (HP:0001946) | 3.33413998 |
| 14 | Xanthomatosis (HP:0000991) | 3.28883983 |
| 15 | Ketoacidosis (HP:0001993) | 3.17719991 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.17219051 |
| 17 | Obstructive sleep apnea (HP:0002870) | 3.11075160 |
| 18 | Hyperglycinuria (HP:0003108) | 3.03363317 |
| 19 | Intrahepatic cholestasis (HP:0001406) | 3.01305586 |
| 20 | Decreased central vision (HP:0007663) | 2.96011653 |
| 21 | Hyperammonemia (HP:0001987) | 2.89506256 |
| 22 | Gout (HP:0001997) | 2.85658320 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 2.84657763 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.84134752 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 2.84134752 |
| 26 | Attenuation of retinal blood vessels (HP:0007843) | 2.77137721 |
| 27 | Macular degeneration (HP:0000608) | 2.74818088 |
| 28 | Myokymia (HP:0002411) | 2.74088393 |
| 29 | Pendular nystagmus (HP:0012043) | 2.71749245 |
| 30 | Posterior subcapsular cataract (HP:0007787) | 2.71640896 |
| 31 | Type II diabetes mellitus (HP:0005978) | 2.68899278 |
| 32 | Protrusio acetabuli (HP:0003179) | 2.67755083 |
| 33 | Hypoglycemic coma (HP:0001325) | 2.65924063 |
| 34 | Distal lower limb muscle weakness (HP:0009053) | 2.63651091 |
| 35 | Dysostosis multiplex (HP:0000943) | 2.61434066 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 2.60893357 |
| 37 | Asymmetric septal hypertrophy (HP:0001670) | 2.60885839 |
| 38 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.56591815 |
| 39 | Hyperglycinemia (HP:0002154) | 2.53999498 |
| 40 | Myoglobinuria (HP:0002913) | 2.53556915 |
| 41 | Retinal atrophy (HP:0001105) | 2.50923062 |
| 42 | Eczematoid dermatitis (HP:0000976) | 2.50812330 |
| 43 | Complement deficiency (HP:0004431) | 2.50298707 |
| 44 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.50195293 |
| 45 | Cone-rod dystrophy (HP:0000548) | 2.49846513 |
| 46 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.48305323 |
| 47 | Hypoalphalipoproteinemia (HP:0003233) | 2.47873721 |
| 48 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.46688031 |
| 49 | Cerebral aneurysm (HP:0004944) | 2.46566277 |
| 50 | Hyperacusis (HP:0010780) | 2.46391450 |
| 51 | Exercise-induced myalgia (HP:0003738) | 2.44263692 |
| 52 | Increased connective tissue (HP:0009025) | 2.43746986 |
| 53 | Abnormality of complement system (HP:0005339) | 2.41204292 |
| 54 | Epidermoid cyst (HP:0200040) | 2.40024164 |
| 55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35726424 |
| 56 | Mucopolysacchariduria (HP:0008155) | 2.35726424 |
| 57 | Distal lower limb amyotrophy (HP:0008944) | 2.34332724 |
| 58 | Action tremor (HP:0002345) | 2.34318582 |
| 59 | Thin bony cortex (HP:0002753) | 2.31679400 |
| 60 | Broad face (HP:0000283) | 2.31197432 |
| 61 | Hemorrhage of the eye (HP:0011885) | 2.30941686 |
| 62 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.30468117 |
| 63 | Choroideremia (HP:0001139) | 2.28456768 |
| 64 | Dysmetric saccades (HP:0000641) | 2.28446512 |
| 65 | Subcapsular cataract (HP:0000523) | 2.26011441 |
| 66 | Dysdiadochokinesis (HP:0002075) | 2.25742376 |
| 67 | Flat acetabular roof (HP:0003180) | 2.25094646 |
| 68 | Photophobia (HP:0000613) | 2.25020000 |
| 69 | Increased variability in muscle fiber diameter (HP:0003557) | 2.24335086 |
| 70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24303546 |
| 71 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24303546 |
| 72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24303546 |
| 73 | Abnormality of the lower motor neuron (HP:0002366) | 2.22220924 |
| 74 | Type 1 muscle fiber predominance (HP:0003803) | 2.21415086 |
| 75 | Visual hallucinations (HP:0002367) | 2.19729072 |
| 76 | Vitreoretinal degeneration (HP:0000655) | 2.18517931 |
| 77 | Vertebral compression fractures (HP:0002953) | 2.18355177 |
| 78 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18306385 |
| 79 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18306385 |
| 80 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18306385 |
| 81 | Hypobetalipoproteinemia (HP:0003563) | 2.17732203 |
| 82 | Hypolipoproteinemia (HP:0010981) | 2.17283502 |
| 83 | Achilles tendon contracture (HP:0001771) | 2.14252614 |
| 84 | Status epilepticus (HP:0002133) | 2.13262276 |
| 85 | Intention tremor (HP:0002080) | 2.11509644 |
| 86 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.08653597 |
| 87 | Polycythemia (HP:0001901) | 2.05760684 |
| 88 | Neurofibrillary tangles (HP:0002185) | 2.04688717 |
| 89 | Increased cerebral lipofuscin (HP:0011813) | 2.04060932 |
| 90 | Postural instability (HP:0002172) | 2.03262830 |
| 91 | Emphysema (HP:0002097) | 2.02294943 |
| 92 | Aneurysm (HP:0002617) | 2.01925934 |
| 93 | Supranuclear gaze palsy (HP:0000605) | 2.01791738 |
| 94 | Ventricular fibrillation (HP:0001663) | 2.01741693 |
| 95 | Increased circulating renin level (HP:0000848) | 2.01133884 |
| 96 | Distal upper limb amyotrophy (HP:0007149) | 2.01072935 |
| 97 | Upper limb amyotrophy (HP:0009129) | 2.01072935 |
| 98 | Malnutrition (HP:0004395) | 2.00474534 |
| 99 | Bundle branch block (HP:0011710) | 2.00071126 |
| 100 | Increased IgE level (HP:0003212) | 1.98127055 |
| 101 | Gastrointestinal stroma tumor (HP:0100723) | 1.96960152 |
| 102 | Prolonged partial thromboplastin time (HP:0003645) | 1.96652356 |
| 103 | Retinitis pigmentosa (HP:0000510) | 1.96215815 |
| 104 | Hyperparathyroidism (HP:0000843) | 1.96191002 |
| 105 | Sensorimotor neuropathy (HP:0007141) | 1.96180702 |
| 106 | Abnormality of purine metabolism (HP:0004352) | 1.96065219 |
| 107 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.95373283 |
| 108 | Cerebral inclusion bodies (HP:0100314) | 1.95077181 |
| 109 | Delayed CNS myelination (HP:0002188) | 1.94399522 |
| 110 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.93352077 |
| 111 | Glomerulonephritis (HP:0000099) | 1.92139637 |
| 112 | Abnormality of the common coagulation pathway (HP:0010990) | 1.91193360 |
| 113 | Abnormal gallbladder physiology (HP:0012438) | 1.90913193 |
| 114 | Cholecystitis (HP:0001082) | 1.90913193 |
| 115 | Increased purine levels (HP:0004368) | 1.88608320 |
| 116 | Hyperuricemia (HP:0002149) | 1.88608320 |
| 117 | Neonatal onset (HP:0003623) | 1.88400960 |
| 118 | Hypercortisolism (HP:0001578) | 1.88338904 |
| 119 | Focal motor seizures (HP:0011153) | 1.88147555 |
| 120 | Cellulitis (HP:0100658) | 1.87346964 |
| 121 | Hypokalemic alkalosis (HP:0001949) | 1.86004134 |
| 122 | Interstitial pulmonary disease (HP:0006530) | 1.84303167 |
| 123 | Impaired social interactions (HP:0000735) | 1.83842533 |
| 124 | Abnormal social behavior (HP:0012433) | 1.83842533 |
| 125 | Pheochromocytoma (HP:0002666) | 1.83774623 |
| 126 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.83683249 |
| 127 | Loss of speech (HP:0002371) | 1.83595223 |
| 128 | Focal seizures (HP:0007359) | 1.83529557 |
| 129 | Premature rupture of membranes (HP:0001788) | 1.82395449 |
| 130 | Colitis (HP:0002583) | 1.81986079 |
| 131 | Neuronal loss in central nervous system (HP:0002529) | 1.81756987 |
| 132 | Progressive visual loss (HP:0000529) | 1.81560386 |
| 133 | Abnormality of macrophages (HP:0004311) | 1.81130542 |
| 134 | Stridor (HP:0010307) | 1.81114143 |
| 135 | Constricted visual fields (HP:0001133) | 1.80770679 |
| 136 | Hyporeflexia of lower limbs (HP:0002600) | 1.80689470 |
| 137 | Sudden death (HP:0001699) | 1.79756355 |
| 138 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.77363154 |
| 139 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.76725486 |
| 140 | Myopathic facies (HP:0002058) | 1.75754613 |
| 141 | Amyloidosis (HP:0011034) | 1.75619146 |
| 142 | Progressive cerebellar ataxia (HP:0002073) | 1.75196795 |
| 143 | Myocardial infarction (HP:0001658) | 1.74959761 |
| 144 | Arterial tortuosity (HP:0005116) | 1.74847861 |
| 145 | Difficulty running (HP:0009046) | 1.74633956 |
| 146 | Gingivitis (HP:0000230) | 1.74439006 |
| 147 | Osteolytic defects of the hand bones (HP:0009699) | 1.74200404 |
| 148 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.74200404 |
| 149 | Abnormality of the fingertips (HP:0001211) | 1.74046083 |
| 150 | Depression (HP:0000716) | 1.73646906 |
| 151 | Torticollis (HP:0000473) | 1.73643744 |
| 152 | Metabolic alkalosis (HP:0200114) | 1.73114970 |
| 153 | Purpura (HP:0000979) | 1.72962327 |
| 154 | Axonal loss (HP:0003447) | 1.72692499 |
| 155 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.72495778 |
| 156 | Abnormality of the nasal mucosa (HP:0000433) | 1.72469714 |
| 157 | Vascular tortuosity (HP:0004948) | 1.72279580 |
| 158 | Syncope (HP:0001279) | 1.71966123 |
| 159 | Prolonged QT interval (HP:0001657) | 1.71505048 |
| 160 | Mitral regurgitation (HP:0001653) | 1.71467235 |
| 161 | J-shaped sella turcica (HP:0002680) | 1.71452056 |
| 162 | Hemiplegia (HP:0002301) | 1.71109689 |
| 163 | Exercise-induced muscle cramps (HP:0003710) | 1.71018451 |
| 164 | Hyperventilation (HP:0002883) | 1.70401903 |
| 165 | Abnormality of the Achilles tendon (HP:0005109) | 1.70083542 |
| 166 | Foot dorsiflexor weakness (HP:0009027) | 1.70079299 |
| 167 | Polygenic inheritance (HP:0010982) | 1.68813718 |
| 168 | Cervical subluxation (HP:0003308) | 1.68706771 |
| 169 | Lower limb amyotrophy (HP:0007210) | 1.67813997 |
| 170 | Ankle clonus (HP:0011448) | 1.66323681 |
| 171 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.66190222 |
| 172 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.65239849 |
| 173 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.63298638 |
| 174 | Onion bulb formation (HP:0003383) | 1.62731082 |
| 175 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.61586997 |
| 176 | Ulnar bowing (HP:0003031) | 1.61586938 |
| 177 | Insomnia (HP:0100785) | 1.61160986 |
| 178 | Spinal rigidity (HP:0003306) | 1.60711108 |
| 179 | Aortic aneurysm (HP:0004942) | 1.60586963 |
| 180 | Mitral stenosis (HP:0001718) | 1.60145434 |
| 181 | Bone pain (HP:0002653) | 1.59789499 |
| 182 | Abnormality of the thoracic spine (HP:0100711) | 1.58608487 |
| 183 | Fragile skin (HP:0001030) | 1.57357418 |
| 184 | Dilatation of the ascending aorta (HP:0005111) | 1.57191691 |
| 185 | Nephritis (HP:0000123) | 1.55340682 |
| 186 | Slow saccadic eye movements (HP:0000514) | 1.55273376 |
| 187 | Disproportionate tall stature (HP:0001519) | 1.55038536 |
| 188 | Muscle fiber splitting (HP:0003555) | 1.52833835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.69427542 |
| 2 | TRIB3 | 2.82156655 |
| 3 | PRKD3 | 2.51709656 |
| 4 | EEF2K | 2.42484126 |
| 5 | RIPK4 | 2.35172308 |
| 6 | PDK4 | 2.32106313 |
| 7 | PDK3 | 2.32106313 |
| 8 | EPHA4 | 2.24823616 |
| 9 | IRAK3 | 2.23018224 |
| 10 | SMG1 | 2.18853120 |
| 11 | PINK1 | 2.17518193 |
| 12 | MAP3K13 | 2.02785109 |
| 13 | PAK6 | 2.00455322 |
| 14 | MAP3K9 | 1.98895023 |
| 15 | GRK1 | 1.96913843 |
| 16 | BCKDK | 1.94938110 |
| 17 | STK38 | 1.92010740 |
| 18 | WNK4 | 1.90758500 |
| 19 | LMTK2 | 1.89855337 |
| 20 | RIPK1 | 1.86653884 |
| 21 | NTRK3 | 1.85493015 |
| 22 | PHKG1 | 1.80766728 |
| 23 | PHKG2 | 1.80766728 |
| 24 | SIK1 | 1.78017778 |
| 25 | DAPK2 | 1.72880795 |
| 26 | CAMKK1 | 1.72126448 |
| 27 | MAP3K4 | 1.68551126 |
| 28 | CAMK1G | 1.62039307 |
| 29 | MAP2K4 | 1.60935496 |
| 30 | MARK1 | 1.60652474 |
| 31 | MAP2K3 | 1.55323659 |
| 32 | CDK12 | 1.53665983 |
| 33 | PKN2 | 1.51525982 |
| 34 | ICK | 1.48298226 |
| 35 | KSR2 | 1.46987324 |
| 36 | TYK2 | 1.40897183 |
| 37 | MINK1 | 1.38981457 |
| 38 | PDK2 | 1.38941370 |
| 39 | MAP3K3 | 1.38882254 |
| 40 | PRKCH | 1.32971881 |
| 41 | NTRK2 | 1.24832974 |
| 42 | MAP3K7 | 1.24632405 |
| 43 | MAP4K1 | 1.24187152 |
| 44 | NTRK1 | 1.24165166 |
| 45 | TAOK2 | 1.23363815 |
| 46 | MAP3K14 | 1.22280357 |
| 47 | SGK223 | 1.21465166 |
| 48 | SGK494 | 1.21465166 |
| 49 | FGFR4 | 1.20809821 |
| 50 | SGK3 | 1.17641413 |
| 51 | ERN1 | 1.17186079 |
| 52 | FGFR3 | 1.17132653 |
| 53 | CAMK1D | 1.15140121 |
| 54 | NEK1 | 1.14863335 |
| 55 | WNK1 | 1.14303122 |
| 56 | STK39 | 1.14008111 |
| 57 | OXSR1 | 1.13354413 |
| 58 | DDR2 | 1.10870831 |
| 59 | TBK1 | 1.10260028 |
| 60 | MAP3K2 | 1.09204283 |
| 61 | MAPKAPK3 | 1.08529155 |
| 62 | TYRO3 | 1.07715883 |
| 63 | INSRR | 1.06650596 |
| 64 | SIK2 | 1.05711917 |
| 65 | PRKD2 | 1.02890314 |
| 66 | PDPK1 | 1.01513313 |
| 67 | MAPK11 | 1.01363482 |
| 68 | RET | 1.01337815 |
| 69 | PDK1 | 1.00211981 |
| 70 | PAK3 | 0.97144135 |
| 71 | WNK3 | 0.96884234 |
| 72 | ARAF | 0.95802277 |
| 73 | FGFR2 | 0.94618015 |
| 74 | MAP3K11 | 0.93865196 |
| 75 | CDK5 | 0.93580279 |
| 76 | BLK | 0.92523104 |
| 77 | MAPK12 | 0.91765935 |
| 78 | NEK9 | 0.90040491 |
| 79 | SGK2 | 0.87771036 |
| 80 | MTOR | 0.87241404 |
| 81 | STK11 | 0.85983817 |
| 82 | PTK6 | 0.85350329 |
| 83 | TAOK1 | 0.85318182 |
| 84 | ZAP70 | 0.85236015 |
| 85 | EPHA2 | 0.84245282 |
| 86 | RPS6KA2 | 0.82771516 |
| 87 | TRPM7 | 0.78673769 |
| 88 | PRKAA1 | 0.77956315 |
| 89 | PDGFRA | 0.77366021 |
| 90 | PRKCZ | 0.76284813 |
| 91 | IRAK2 | 0.75814422 |
| 92 | PRKCG | 0.74083472 |
| 93 | JAK3 | 0.73987373 |
| 94 | TTN | 0.73570132 |
| 95 | TNK2 | 0.71906652 |
| 96 | MST1R | 0.71562519 |
| 97 | MARK2 | 0.68477093 |
| 98 | DMPK | 0.68313671 |
| 99 | HIPK2 | 0.67067670 |
| 100 | CAMK1 | 0.66138005 |
| 101 | CSK | 0.65268020 |
| 102 | PRKD1 | 0.65019348 |
| 103 | PRKACG | 0.61472864 |
| 104 | IRAK4 | 0.61045871 |
| 105 | MAP3K10 | 0.60491116 |
| 106 | LRRK2 | 0.60274836 |
| 107 | PRKAA2 | 0.60118126 |
| 108 | LATS2 | 0.60105152 |
| 109 | SCYL2 | 0.59237234 |
| 110 | SGK1 | 0.57386262 |
| 111 | NME2 | 0.56184268 |
| 112 | JAK1 | 0.55694631 |
| 113 | ERBB2 | 0.55650312 |
| 114 | RPS6KA3 | 0.55127616 |
| 115 | RPS6KC1 | 0.54824038 |
| 116 | RPS6KL1 | 0.54824038 |
| 117 | KSR1 | 0.53895587 |
| 118 | MAP3K1 | 0.53572479 |
| 119 | CDC42BPA | 0.53445954 |
| 120 | PTK2B | 0.53405704 |
| 121 | EPHB1 | 0.53047890 |
| 122 | CAMK2A | 0.52090237 |
| 123 | ALK | 0.51139445 |
| 124 | DYRK1B | 0.51079879 |
| 125 | CAMK4 | 0.50811445 |
| 126 | TESK1 | 0.50105870 |
| 127 | GRK5 | 0.49484899 |
| 128 | MAP2K7 | 0.49315224 |
| 129 | CAMK2G | 0.48963602 |
| 130 | LATS1 | 0.47396557 |
| 131 | CAMK2D | 0.47291608 |
| 132 | PDGFRB | 0.46221635 |
| 133 | JAK2 | 0.46192212 |
| 134 | MAPK4 | 0.46091027 |
| 135 | PTK2 | 0.45908004 |
| 136 | PKN1 | 0.45790901 |
| 137 | ROCK1 | 0.43853083 |
| 138 | PIM2 | 0.43820344 |
| 139 | PRKG2 | 0.42559263 |
| 140 | FER | 0.41929209 |
| 141 | CAMKK2 | 0.41558712 |
| 142 | MELK | 0.41555339 |
| 143 | MAP3K6 | 0.41460084 |
| 144 | IKBKE | 0.40527804 |
| 145 | PNCK | 0.40178823 |
| 146 | BMX | 0.40122867 |
| 147 | HCK | 0.39903352 |
| 148 | MAPK7 | 0.39870685 |
| 149 | CSF1R | 0.38683618 |
| 150 | GRK6 | 0.38580795 |
| 151 | RPS6KA6 | 0.37475445 |
| 152 | SYK | 0.37395711 |
| 153 | MAP2K1 | 0.36953871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 4.38408000 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.09519485 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.74266856 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.35019954 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.26609784 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.26132189 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23732284 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.12240822 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.04665401 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01428881 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.97019344 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.93435728 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91867390 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.88488915 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.85500915 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.74898980 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72053919 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.66862503 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.65753149 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.56555313 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.56241406 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47358279 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.44365111 |
| 24 | Prion diseases_Homo sapiens_hsa05020 | 1.41722068 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41073859 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41035932 |
| 27 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.39641542 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36042000 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.35176191 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32163280 |
| 31 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.30711561 |
| 32 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.30105019 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.29675453 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.23393650 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21646938 |
| 36 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.21504002 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.20554555 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19346616 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19003037 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.18622117 |
| 41 | GABAergic synapse_Homo sapiens_hsa04727 | 1.16774116 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14592597 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11719103 |
| 44 | Olfactory transduction_Homo sapiens_hsa04740 | 1.11607852 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.11223920 |
| 46 | Leishmaniasis_Homo sapiens_hsa05140 | 1.10880070 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09778330 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.09185161 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.06737163 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.05063846 |
| 51 | Glioma_Homo sapiens_hsa05214 | 1.04662889 |
| 52 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.03283678 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02565125 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 1.00386305 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99827613 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99439952 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98052177 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95881656 |
| 59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95792664 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.93792044 |
| 61 | Insulin secretion_Homo sapiens_hsa04911 | 0.92675850 |
| 62 | Circadian entrainment_Homo sapiens_hsa04713 | 0.92295127 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92006714 |
| 64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.91219370 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90427140 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.90323148 |
| 67 | Tuberculosis_Homo sapiens_hsa05152 | 0.90263858 |
| 68 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.90112971 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.90027166 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.89825824 |
| 71 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88679151 |
| 72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.87980048 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87883620 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.87574487 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.87331900 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86431467 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86055651 |
| 78 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84724695 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84286163 |
| 80 | Salivary secretion_Homo sapiens_hsa04970 | 0.82133491 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80981117 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79855445 |
| 83 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.79509866 |
| 84 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78465667 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.78112755 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.77574873 |
| 87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77299201 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77210423 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77136049 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77090991 |
| 91 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76250740 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76089025 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.75485470 |
| 94 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75438102 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75252233 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75077750 |
| 97 | Focal adhesion_Homo sapiens_hsa04510 | 0.74494300 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.73581603 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73568624 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.73307981 |
| 101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73271371 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.72049973 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.71080907 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70924846 |
| 105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70916596 |
| 106 | Nicotine addiction_Homo sapiens_hsa05033 | 0.70708683 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70417858 |
| 108 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69740381 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69492739 |
| 110 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.69368000 |
| 111 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69265854 |
| 112 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69191687 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.67908253 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67567015 |
| 115 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66931673 |
| 116 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66455203 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66360898 |
| 118 | Renin secretion_Homo sapiens_hsa04924 | 0.66348507 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65941163 |
| 120 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65820643 |
| 121 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64629581 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63464216 |
| 123 | Platelet activation_Homo sapiens_hsa04611 | 0.62259789 |
| 124 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62150996 |
| 125 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.61277107 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.60115464 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.59347042 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59214418 |
| 129 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58591757 |
| 130 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56636827 |
| 131 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56614695 |
| 132 | Measles_Homo sapiens_hsa05162 | 0.56433269 |
| 133 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56193133 |
| 134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55955510 |
| 135 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55847804 |
| 136 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55240183 |
| 137 | Allograft rejection_Homo sapiens_hsa05330 | 0.55025242 |
| 138 | Prostate cancer_Homo sapiens_hsa05215 | 0.53913750 |
| 139 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53164910 |
| 140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53114405 |
| 141 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53007877 |
| 142 | Apoptosis_Homo sapiens_hsa04210 | 0.52586972 |
| 143 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51659213 |
| 144 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51273182 |
| 145 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50777349 |
| 146 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50625808 |
| 147 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50153373 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49355826 |
| 149 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49250631 |
| 150 | Cocaine addiction_Homo sapiens_hsa05030 | 0.48901027 |
| 151 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48053983 |
| 152 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47577133 |
| 153 | Malaria_Homo sapiens_hsa05144 | 0.47275752 |
| 154 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41484313 |
| 155 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40943115 |
| 156 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40135293 |
| 157 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40079927 |
| 158 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.38594643 |
| 159 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37139687 |
| 160 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35792631 |
| 161 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35703469 |
| 162 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35195727 |
| 163 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.35032040 |
| 164 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34546423 |
| 165 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34213053 |
| 166 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33827694 |
| 167 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33547600 |

